The primary claim in Elmiron lawsuits is that the company failed to warn about the dangerous side effects of the drug. The packaging and warning label did not list maculopathy as a risk prior to June 16, 2020. Therefore, doctors were unaware of this complication of Elmiron's use. Had they known, they may not have prescribed it. And many patients may have chosen not to take it.